Among those specifically dysregulated genes in castration-resistant samples, EP4 (PTGER4) was listed in our Table 5 and it's a validated target for the treatment of castration-resistant prostate cancer [5]. The gene discussed is PTGER4; the disease is prostate carcinoma.